Financial reports
10-Q
2015 Q1
Quarterly report
6 May 15
10-K/A
2014 FY
Annual report (amended)
29 Apr 15
10-K
2014 FY
Annual report
4 Mar 15
10-Q
2014 Q3
Quarterly report
6 Nov 14
10-Q
2014 Q2
Quarterly report
8 Aug 14
10-Q
2014 Q1
Quarterly report
7 May 14
10-K
2013 FY
Annual report
7 Mar 14
10-Q
2013 Q3
Quarterly report
12 Nov 13
10-Q
2013 Q1
Quarterly report
10 May 13
Current reports
8-K
Completion of Acquisition or Disposition of Assets
7 May 15
8-K
Results of Operations and Financial Condition
9 Apr 15
8-K/A
Entry into a Material Definitive Agreement
9 Apr 15
8-K
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per share or $1.1 Billion in Cash
30 Mar 15
8-K
UCD Product Portfolio Generates $113.6 Million for Fiscal Year 2014 and $30.8 Million in Net Sales During the Fourth Quarter of 2014
26 Feb 15
8-K
Hyperion Therapeutics Enters Into Completion of Phase III Clinical Trial, Option and Mutual Release
17 Feb 15
8-K
Departure of Directors or Certain Officers
10 Feb 15
8-K
Results of Operations and Financial Condition
6 Nov 14
8-K
Material Impairments
8 Sep 14
8-K
Departure of Directors or Certain Officers
12 Aug 14
Registration and prospectus
15-12B
Securities registration termination
18 May 15
25-NSE
Exchange delisting
7 May 15
RW
Registration withdrawal request
7 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
7 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
7 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
7 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
7 May 15
SC 14D9/A
Tender offer solicitation (amended)
7 May 15
SC TO-T/A
Third party tender offer statement (amended)
7 May 15
SC 14D9/A
Tender offer solicitation (amended)
30 Apr 15
Proxies
Other
CT ORDER
Confidential treatment order
1 Jun 15
UPLOAD
Letter from SEC
14 May 15
CORRESP
Correspondence with SEC
22 Apr 15
UPLOAD
Letter from SEC
20 Apr 15
CT ORDER
Confidential treatment order
10 Oct 14
CT ORDER
Confidential treatment order
29 Apr 14
CT ORDER
Confidential treatment order
22 Nov 13
EFFECT
Notice of effectiveness
13 Sep 13
EFFECT
Notice of effectiveness
7 Mar 13
CORRESP
Correspondence with SEC
5 Mar 13
Ownership
SC 13G/A
Hyperion Therapeutics Inc
11 Feb 16
SC 13D/A
Hyperion Therapeutics Inc
15 May 15
4
Change in insider ownership
11 May 15
4
M JAMES BARRETT
11 May 15
4
Jason Raleigh Nunn
11 May 15
4
FOREST BASKETT
11 May 15
4
PATRICK J KERINS
11 May 15
4
SCOTT D SANDELL
11 May 15
4
RYAN D DRANT
11 May 15
4
PETER J BARRIS
11 May 15